Trexquant Investment’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-18,568
| Closed | -$444K | – | 1940 |
|
|
2025
Q3 | $444K | Sell |
18,568
-53,776
| -74% | -$1.01M | ﹤0.01% | 1338 |
|
|
2025
Q2 | $1.07M | Sell |
72,344
-84,056
| -54% | -$1.39M | 0.01% | 1089 |
|
|
2025
Q1 | $2.8M | Sell |
156,400
-123,817
| -44% | -$2.51M | 0.03% | 743 |
|
|
2024
Q4 | $4.88M | Sell |
280,217
-76,491
| -21% | -$1.35M | 0.06% | 536 |
|
|
2024
Q3 | $4.99M | Buy |
356,708
+182,220
| +104% | +$1.9M | 0.06% | 477 |
|
|
2024
Q2 | $1.43M | Buy |
+174,488
| New | +$1.18M | 0.02% | 873 |
|
|
2023
Q3 | – | Sell |
-120,990
| Closed | -$1.86M | – | 1839 |
|
|
2023
Q2 | $1.86M | Buy |
120,990
+46,106
| +62% | +$839K | 0.05% | 516 |
|
|
2023
Q1 | $1.68M | Buy |
+74,884
| New | +$1.59M | 0.05% | 520 |
|
|
2022
Q4 | – | Sell |
-10,579
| Closed | -$261K | – | 1744 |
|
|
2022
Q3 | $261K | Sell |
10,579
-7,858
| -43% | -$203K | 0.01% | 1091 |
|
|
2022
Q2 | $447K | Sell |
18,437
-31,848
| -63% | -$801K | 0.02% | 892 |
|
|
2022
Q1 | $1.3M | Buy |
50,285
+40,614
| +420% | +$1.08M | 0.06% | 384 |
|
|
2021
Q4 | $300K | Buy |
+9,671
| New | +$272K | 0.02% | 921 |
|
|
2021
Q3 | – | Sell |
-19,990
| Closed | -$292K | – | 1502 |
|
|
2021
Q2 | $292K | Buy |
+19,990
| New | +$394K | 0.02% | 728 |
|
|
2020
Q4 | – | Sell |
-43,711
| Closed | -$807K | – | 1499 |
|
|
2020
Q3 | $807K | Buy |
43,711
+15,360
| +54% | +$299K | 0.05% | 494 |
|
|
2020
Q2 | $579K | Sell |
28,351
-7,277
| -20% | -$116K | 0.04% | 615 |
|
|
2020
Q1 | $520K | Buy |
35,628
+11,095
| +45% | +$167K | 0.04% | 641 |
|
|
2019
Q4 | $348K | Buy |
24,533
+1,200
| +5% | +$15.3K | 0.02% | 688 |
|
|
2019
Q3 | $270K | Buy |
+23,333
| New | +$386K | 0.02% | 650 |
|
|
2019
Q2 | – | Sell |
-17,048
| Closed | -$386K | – | 1133 |
|
|
2019
Q1 | $386K | Sell |
17,048
-12,441
| -42% | -$275K | 0.03% | 664 |
|
|
2018
Q4 | $667K | Buy |
+29,489
| New | +$734K | 0.04% | 539 |
|
|
2018
Q3 | – | Sell |
-10,000
| Closed | -$273K | – | 1208 |
|
|
2018
Q2 | $273K | Buy |
+10,000
| New | +$266K | 0.02% | 708 |
|
|
2017
Q4 | – | Sell |
-8,154
| Closed | -$203K | – | 1261 |
|
|
2017
Q3 | $203K | Buy |
+8,154
| New | +$180K | 0.05% | 635 |
|
|
2016
Q2 | – | Sell |
-16,332
| Closed | -$223K | – | 1115 |
|
|
2016
Q1 | $223K | Sell |
16,332
-24,068
| -60% | -$365K | 0.03% | 817 |
|
|
2015
Q4 | $779K | Buy |
40,400
+22,700
| +128% | +$453K | 0.07% | 496 |
|
|
2015
Q3 | $358K | Sell |
17,700
-19,100
| -52% | -$566K | 0.03% | 830 |
|
|
2015
Q2 | $1.22M | Buy |
+36,800
| New | +$1.01M | 0.14% | 259 |
|
|
2015
Q1 | – | Sell |
-14,670
| Closed | -$179K | – | 1199 |
|
|
2014
Q4 | $179K | Buy |
+14,670
| New | +$152K | 0.03% | 823 |
|
Other funds holding TVTX
PA
NAMI
AC
Trexquant Investment's TVTX Position: Q4 2025 in Review
Trexquant Investment sold out of Travere Therapeutics (TVTX) in Q4 2025, closing a stake of 18,568 shares — an estimated $444K sold.
Trexquant Investment first reported a position in TVTX in Q4 2014 and held it in 27 quarters. The position peaked at $4.99M in Q3 2024. 278 funds tracked by Wall St. Rank hold TVTX as of Q4 2025.
- Trexquant Investment reported no remaining Travere Therapeutics position as of Q4 2025 after selling out during the quarter.
- Trexquant Investment sold 18,568 Travere Therapeutics shares in Q4 2025, an estimated $444K.
- Trexquant Investment first reported a position in Travere Therapeutics in Q4 2014 and held it in 27 quarters.
- Trexquant Investment's Travere Therapeutics position peaked at $4.99M in Q3 2024.
- 278 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2025.
Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.